Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2005 | 06-2005 | 03-2001 | |
| Cash Flows From Operating Activities | |||
| Net Income | -15 | -15 | N/A |
| Other Working Capital | 15 | 15 | N/A |
| Operating Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | N/A | N/A | 4,608 |
| PPE Investments | N/A | N/A | 46 |
| Investing Cash Flow | $N/A | $N/A | $4,654 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 25 | 25 | N/A |
| Other Financing Activity | -19 | 11 | 0 |
| Financing Cash Flow | $6 | $36 | $N/A |
| End Cash Position | 6 | 36 | N/A |
| Net Cash Flow | $6 | $36 | $4,654 |
| Free Cash Flow | |||